FDA Import Refusal 799-4641353-1/11/3 — CADILA PHARMA LTD

CADILA PHARMA LTD — FEI 3027057150

The FDA refused shipment 799-4641353-1/11/3 from CADILA PHARMA LTD (India) on May 4, 2023. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 2 other import refusals on record.

Refusal Details

Date
May 4, 2023
Country
India
Product Category
Drugs and Biologics
Product Code
62OCB14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.